Literature DB >> 27892808

Self-reported impulsivity in Huntington's disease patients and relationship to executive dysfunction and reward responsiveness.

Patricia L Johnson1, Geoffrey F Potts1, Juan Sanchez-Ramos2, Cynthia R Cimino1,2.   

Abstract

INTRODUCTION: Few studies have directly investigated impulsivity in Huntington's disease (HD) despite known changes in dopaminergic and frontal functioning, changes that have been associated with impulsivity in other disorders and in the normal population. This study sought to further categorize impulsivity in HD through examining differences in self-reported impulsivity between community controls and HD patients, the relationship between executive dysfunction and impulsivity, and the relationship of a reward/punishment behavioral inhibition task in relation to these self-report measures. It was expected that HD patients would report higher impulsivity and executive dysfunction and that these measures would relate to a reward/punishment behavioral inhibition task.
METHOD: The Barratt Impulsivity Scale (BIS-11) and Behavioral Inhibition/Behavioral Activation Scale (BIS/BAS) were completed, and the Mini-Mental State Examination (MMSE) and a reward-based flanker task with punishing and rewarding conditions were administered to 22 HD patients and 14 control participants.
RESULTS: HD patients reported higher trait impulsivity (BIS-11) and executive dysfunction (Frontal Systems Behavior Scale, FrSBE) but not increased impulsivity on the BIS/BAS relative to controls. Higher BIS-11 scores were related to increased self-reported executive dysfunction and the attention/working memory factor of the MMSE. On a reward/punishment behavioral inhibition task, BAS was uniquely related to increased accuracy on rewarding trials of the flanker task, but was not related to punishing trials in HD patients.
CONCLUSIONS: The relationships found suggest that trait impulsivity is reported higher in HD and may not be driven by altered reward evaluation and the appetitive nature of stimuli but rather by increased executive dysfunction and lack of sensitivity to punishment. Impulsivity in HD may represent a combination of trait impulsivity, altered dopaminergic circuitry, and executive dysfunction. Understanding impulsivity in HD is important as it is related to increased risk to the patient and difficult behaviors for the caregiver, and sheds light on the disease process.

Entities:  

Keywords:  Executive dysfunction; Huntington’s disease; Impulsivity; Punishment; Reward.

Mesh:

Year:  2016        PMID: 27892808     DOI: 10.1080/13803395.2016.1257702

Source DB:  PubMed          Journal:  J Clin Exp Neuropsychol        ISSN: 1380-3395            Impact factor:   2.475


  6 in total

1.  Suicidality Risk Factors Across the CARE-HD, 2CARE, and CREST-E Clinical Trials in Huntington Disease.

Authors:  Andrew McGarry; Peggy Auinger; Karl D Kieburtz; Amy-Lee Bredlau; Steven M Hersch; H Diana Rosas
Journal:  Neurol Clin Pract       Date:  2022-04

2.  Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease.

Authors:  Tiffany X Chen; Chi-Ying R Lin; Megan A Aumann; Yan Yan; Nadia Amokrane; Natasha A Desai; Hakmook Kang; Daniel O Claassen; Sheng-Han Kuo
Journal:  Neurology       Date:  2022-04-15       Impact factor: 11.800

3.  Reward Responsiveness in the Adolescent Brain Cognitive Development (ABCD) Study: African Americans' Diminished Returns of Parental Education.

Authors:  Shervin Assari; Shanika Boyce; Golnoush Akhlaghipour; Mohsen Bazargan; Cleopatra H Caldwell
Journal:  Brain Sci       Date:  2020-06-19

4.  African American Children's Diminished Returns of Subjective Family Socioeconomic Status on Fun Seeking.

Authors:  Shervin Assari; Golnoush Akhlaghipour; Shanika Boyce; Mohsen Bazargan; Cleopatra H Caldwell
Journal:  Children (Basel)       Date:  2020-07-09

Review 5.  Disordered Decision Making: A Cognitive Framework for Apathy and Impulsivity in Huntington's Disease.

Authors:  Lee-Anne Morris; Claire O'Callaghan; Campbell Le Heron
Journal:  Mov Disord       Date:  2022-05-02       Impact factor: 9.698

6.  Risk factors for suicidality in Huntington disease: An analysis of the 2CARE clinical trial.

Authors:  Andrew McGarry; Michael P McDermott; Karl Kieburtz; Wai Lun Alan Fung; Elizabeth McCusker; Jing Peng; Elisabeth A de Blieck; Merit Cudkowicz
Journal:  Neurology       Date:  2019-03-08       Impact factor: 9.910

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.